rabbit anti nr2a Search Results


nmdar2a antibody  (Bio-Techne corporation)
94
Bio-Techne corporation nmdar2a antibody
Nmdar2a Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nmdar2a antibody/product/Bio-Techne corporation
Average 94 stars, based on 1 article reviews
nmdar2a antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
nr2b antibody (1:500)  (ABclonal Biotechnology)
90
ABclonal Biotechnology nr2b antibody (1:500)
Inhibition of SGK1 Pathway antagonises development of DEX analgesic tolerance (A) Schematic diagram of the experimental procedure. (B–F) represented the PWT (contralateral and ipsilateral), the PWL, TFL, and WBR of the mice in different treatment groups, respectively. SNI+ Vehicle: SNI group; SNI + m‐GSK650394: Multiple GSK650394 injections; SNI + s‐DEX + vehicle: Single DEX injection; SNI + s‐DEX + s‐GSK650394: Single DEX injection + single GSK650394 injection; SNI + m‐DEX + Vehicle: Multiple DEX injections; SNI + m‐DEX + m‐GSK650394: Multiple DEX + multiple GSK650394 injections. (G) Western blotted bands of SGK1 , pSGK1 with GAPDH as an internal control. (H and I) relative protein levels of SGK1 and pSGK1 . (J) Western blotted bands of NR1 , NR2A , and <t>NR2B</t> with GAPDH as an internal control. (L–N) relative protein levels of NR1 , NR2A and NR2B . Data were expressed as mean ± SD. Different letters indicated significant differences among the groups at ( p < 0.05). * p < 0.05 indicates that the measured value at this measurement time point was significantly different from that of the SNI group, ** p < 0.01.
Nr2b Antibody (1:500), supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nr2b antibody (1:500)/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
nr2b antibody (1:500) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rabbit anti-nr2a  (Bimake Inc)
90
Bimake Inc rabbit anti-nr2a
Inhibition of SGK1 Pathway antagonises development of DEX analgesic tolerance (A) Schematic diagram of the experimental procedure. (B–F) represented the PWT (contralateral and ipsilateral), the PWL, TFL, and WBR of the mice in different treatment groups, respectively. SNI+ Vehicle: SNI group; SNI + m‐GSK650394: Multiple GSK650394 injections; SNI + s‐DEX + vehicle: Single DEX injection; SNI + s‐DEX + s‐GSK650394: Single DEX injection + single GSK650394 injection; SNI + m‐DEX + Vehicle: Multiple DEX injections; SNI + m‐DEX + m‐GSK650394: Multiple DEX + multiple GSK650394 injections. (G) Western blotted bands of SGK1 , pSGK1 with GAPDH as an internal control. (H and I) relative protein levels of SGK1 and pSGK1 . (J) Western blotted bands of NR1 , NR2A , and <t>NR2B</t> with GAPDH as an internal control. (L–N) relative protein levels of NR1 , NR2A and NR2B . Data were expressed as mean ± SD. Different letters indicated significant differences among the groups at ( p < 0.05). * p < 0.05 indicates that the measured value at this measurement time point was significantly different from that of the SNI group, ** p < 0.01.
Rabbit Anti Nr2a, supplied by Bimake Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-nr2a/product/Bimake Inc
Average 90 stars, based on 1 article reviews
rabbit anti-nr2a - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Inhibition of SGK1 Pathway antagonises development of DEX analgesic tolerance (A) Schematic diagram of the experimental procedure. (B–F) represented the PWT (contralateral and ipsilateral), the PWL, TFL, and WBR of the mice in different treatment groups, respectively. SNI+ Vehicle: SNI group; SNI + m‐GSK650394: Multiple GSK650394 injections; SNI + s‐DEX + vehicle: Single DEX injection; SNI + s‐DEX + s‐GSK650394: Single DEX injection + single GSK650394 injection; SNI + m‐DEX + Vehicle: Multiple DEX injections; SNI + m‐DEX + m‐GSK650394: Multiple DEX + multiple GSK650394 injections. (G) Western blotted bands of SGK1 , pSGK1 with GAPDH as an internal control. (H and I) relative protein levels of SGK1 and pSGK1 . (J) Western blotted bands of NR1 , NR2A , and NR2B with GAPDH as an internal control. (L–N) relative protein levels of NR1 , NR2A and NR2B . Data were expressed as mean ± SD. Different letters indicated significant differences among the groups at ( p < 0.05). * p < 0.05 indicates that the measured value at this measurement time point was significantly different from that of the SNI group, ** p < 0.01.

Journal: Journal of Cellular and Molecular Medicine

Article Title: Elucidation of Dexmedetomidine‐Induced Analgesic Tolerance Mechanisms in Neuropathic Pain With Modulation of SGK1 , NR2A , and NR2B Expression via the Spinal SGK1 / NF ‐ κB Signalling Pathway

doi: 10.1111/jcmm.70372

Figure Lengend Snippet: Inhibition of SGK1 Pathway antagonises development of DEX analgesic tolerance (A) Schematic diagram of the experimental procedure. (B–F) represented the PWT (contralateral and ipsilateral), the PWL, TFL, and WBR of the mice in different treatment groups, respectively. SNI+ Vehicle: SNI group; SNI + m‐GSK650394: Multiple GSK650394 injections; SNI + s‐DEX + vehicle: Single DEX injection; SNI + s‐DEX + s‐GSK650394: Single DEX injection + single GSK650394 injection; SNI + m‐DEX + Vehicle: Multiple DEX injections; SNI + m‐DEX + m‐GSK650394: Multiple DEX + multiple GSK650394 injections. (G) Western blotted bands of SGK1 , pSGK1 with GAPDH as an internal control. (H and I) relative protein levels of SGK1 and pSGK1 . (J) Western blotted bands of NR1 , NR2A , and NR2B with GAPDH as an internal control. (L–N) relative protein levels of NR1 , NR2A and NR2B . Data were expressed as mean ± SD. Different letters indicated significant differences among the groups at ( p < 0.05). * p < 0.05 indicates that the measured value at this measurement time point was significantly different from that of the SNI group, ** p < 0.01.

Article Snippet: NR2B antibody (1:500) , Abclonal Technology Co. Ltd..

Techniques: Inhibition, Injection, Western Blot, Control

Impacts of PDTC on the expression of SGK1 pSGK1 in the spinal cord. (A) Schematic diagram of the experimental procedure. (B–E) represented the PWT (contralateral and ipsilateral), PWL, and TFL in different treatment groups, respectively. SNI + Vehicle: SNI group; SNI + m‐PDTC: Multiple PDTC injections; SNI + s‐DEX + vehicle: Single DEX injection; SNI + s‐DEX + s‐PDTC: Single DEX injection + single PDTC injection; SNI + m‐DEX + Vehicle: Multiple DEX injections; SNI + m‐DEX + m‐PDTC: Multiple DEX injections + multiple PDTC. (F) Western blotted bands of SGK1 , pSGK1 with GAPDH as reference. (G and H) relative protein levels of SGK1 and pSGK1 . (I) Western blotted bands of NR1 , NR2A , and NR2B with GAPDH as internal control. (J–L) relative protein levels of NR1 , NR2A , and NR2B . Data were expressed as mean ± SD. Different letters indicated significant differences among the groups at ( p < 0.05). * p < 0.05 indicates that the measured value at this measurement time point was significantly different from that of the SNI group, ** p < 0.01.

Journal: Journal of Cellular and Molecular Medicine

Article Title: Elucidation of Dexmedetomidine‐Induced Analgesic Tolerance Mechanisms in Neuropathic Pain With Modulation of SGK1 , NR2A , and NR2B Expression via the Spinal SGK1 / NF ‐ κB Signalling Pathway

doi: 10.1111/jcmm.70372

Figure Lengend Snippet: Impacts of PDTC on the expression of SGK1 pSGK1 in the spinal cord. (A) Schematic diagram of the experimental procedure. (B–E) represented the PWT (contralateral and ipsilateral), PWL, and TFL in different treatment groups, respectively. SNI + Vehicle: SNI group; SNI + m‐PDTC: Multiple PDTC injections; SNI + s‐DEX + vehicle: Single DEX injection; SNI + s‐DEX + s‐PDTC: Single DEX injection + single PDTC injection; SNI + m‐DEX + Vehicle: Multiple DEX injections; SNI + m‐DEX + m‐PDTC: Multiple DEX injections + multiple PDTC. (F) Western blotted bands of SGK1 , pSGK1 with GAPDH as reference. (G and H) relative protein levels of SGK1 and pSGK1 . (I) Western blotted bands of NR1 , NR2A , and NR2B with GAPDH as internal control. (J–L) relative protein levels of NR1 , NR2A , and NR2B . Data were expressed as mean ± SD. Different letters indicated significant differences among the groups at ( p < 0.05). * p < 0.05 indicates that the measured value at this measurement time point was significantly different from that of the SNI group, ** p < 0.01.

Article Snippet: NR2B antibody (1:500) , Abclonal Technology Co. Ltd..

Techniques: Expressing, Injection, Western Blot, Control

Sequences of primers used for qRT–PCR.

Journal: Journal of Cellular and Molecular Medicine

Article Title: Elucidation of Dexmedetomidine‐Induced Analgesic Tolerance Mechanisms in Neuropathic Pain With Modulation of SGK1 , NR2A , and NR2B Expression via the Spinal SGK1 / NF ‐ κB Signalling Pathway

doi: 10.1111/jcmm.70372

Figure Lengend Snippet: Sequences of primers used for qRT–PCR.

Article Snippet: NR2B antibody (1:500) , Abclonal Technology Co. Ltd..

Techniques:

Drugs and antibodies used in the study.

Journal: Journal of Cellular and Molecular Medicine

Article Title: Elucidation of Dexmedetomidine‐Induced Analgesic Tolerance Mechanisms in Neuropathic Pain With Modulation of SGK1 , NR2A , and NR2B Expression via the Spinal SGK1 / NF ‐ κB Signalling Pathway

doi: 10.1111/jcmm.70372

Figure Lengend Snippet: Drugs and antibodies used in the study.

Article Snippet: NR2B antibody (1:500) , Abclonal Technology Co. Ltd..

Techniques:

Receptors Expression Profiles in the Spinal Cord of Mice. (A–D) Relative mRNA and protein levels of SGK1 and pSGK1 in the spinal cord of mice. (E) Immunofluorescence image of pSGK1 in the spinal dorsal horn on the modelling side of mice, scale = 200 μm. (F) shows the average fluorescence intensity of pSGK1 in the spinal dorsal horn of mice. (G–I) Changes in protein levels of p65 and p ‐ p65 in the spinal cord of mice. (J) Immunofluorescence image of p ‐ 65 in the spinal cord dorsal horn on the modelling side. Scale bar 200 μm. (K) shows the average fluorescence intensity of p ‐ p65 . (L–R) Relative mRNA and protein levels of NR1 , NR2A , and NR2B in the spinal cord of mice. Data were expressed as mean ± SD. Different letters indicated significant differences among the groups at ( p < 0.05). * p < 0.05 indicates that the measured value at this measurement time point was significantly different from that of the SNI group, ** p < 0.01.

Journal: Journal of Cellular and Molecular Medicine

Article Title: Elucidation of Dexmedetomidine‐Induced Analgesic Tolerance Mechanisms in Neuropathic Pain With Modulation of SGK1 , NR2A , and NR2B Expression via the Spinal SGK1 / NF ‐ κB Signalling Pathway

doi: 10.1111/jcmm.70372

Figure Lengend Snippet: Receptors Expression Profiles in the Spinal Cord of Mice. (A–D) Relative mRNA and protein levels of SGK1 and pSGK1 in the spinal cord of mice. (E) Immunofluorescence image of pSGK1 in the spinal dorsal horn on the modelling side of mice, scale = 200 μm. (F) shows the average fluorescence intensity of pSGK1 in the spinal dorsal horn of mice. (G–I) Changes in protein levels of p65 and p ‐ p65 in the spinal cord of mice. (J) Immunofluorescence image of p ‐ 65 in the spinal cord dorsal horn on the modelling side. Scale bar 200 μm. (K) shows the average fluorescence intensity of p ‐ p65 . (L–R) Relative mRNA and protein levels of NR1 , NR2A , and NR2B in the spinal cord of mice. Data were expressed as mean ± SD. Different letters indicated significant differences among the groups at ( p < 0.05). * p < 0.05 indicates that the measured value at this measurement time point was significantly different from that of the SNI group, ** p < 0.01.

Article Snippet: NR2B antibody (1:500) , Abclonal Technology Co. Ltd..

Techniques: Expressing, Immunofluorescence, Fluorescence